{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:56:13Z","timestamp":1774122973463,"version":"3.50.1"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Neuroleptic malignant syndrome (NMS) and serotonin syndrome (SS) are serious medical conditions associated with commonly prescribed psychiatric medications. Although the mechanisms differ, they can be clinically difficult to distinguish. We report a case of a pediatric patient with complicated psychiatric history that developed features of both syndromes in the setting of polypharmacy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case<\/jats:title>\n            <jats:p>A 12-year-old boy with a history of developmental delay, attention-deficit hyperactivity disorder, and posttraumatic stress disorder presented to the emergency department with behavior changes consisting of delayed reactions, gait instability, drooling, and slowed movements. Ten days before presentation, his outpatient psychiatrist had made multiple medication changes including discontinuation of cyproheptadine (an appetite stimulant) and initiation of aripiprazole. On arrival, the patient was noted to be tachycardia and hypertensive for age. He was disoriented, intermittently agitated, and tremulous with increased tonicity, clonus in the lower extremities, and mydriasis. He was supportively treated with lorazepam and intravenous fluids while discontinuing potential offending agents. His course was complicated by hypertension and agitation managed with dexmedetomidine infusion and benzodiazepines. His mental status, tremors, and laboratory values began to improve over the next 2 days, and eventually transitioned to the inpatient psychiatric unit on hospital day 7.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>Diagnosis of NMS or SS can be difficult when there is overlap between syndromes, particularly in the setting of multiple potential offending agents or underlying developmental delay. In addition, pediatric patients may present atypically as compared with adult patients with the same condition.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The use of antipsychotic medications for young children with behavioral problems has risen dramatically in the last decade, increasing their risk for developing SS or NMS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pec.0000000000001477","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T17:02:48Z","timestamp":1524589368000},"page":"e589-e591","source":"Crossref","is-referenced-by-count":9,"title":["A Mixed Presentation of Serotonin Syndrome vs Neuroleptic Malignant Syndrome in a 12-Year-Old Boy"],"prefix":"10.1097","volume":"36","author":[{"given":"Christie","family":"Sun","sequence":"first","affiliation":[{"name":"Division of Medical Toxicology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Sweet","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, University of California San Diego, San Diego, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia B.","family":"Minns","sequence":"additional","affiliation":[{"name":"Division of Medical Toxicology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiree","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, University of California San Diego, San Diego, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willough","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry, University of California San Diego, San Diego, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00002018-199819010-00006","article-title":"Neuroleptic malignant syndrome. Recognition, prevention and management","volume":"19","year":"1998","journal-title":"Drug Saf"},{"key":"bib2-20231002","article-title":"Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary","volume":"2014","year":"2014","journal-title":"BMJ Case Rep"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ajp.2015.10.003","article-title":"Serotonin syndrome overlapping with neuroleptic malignant syndrome: a case report and approaches for differentially diagnosing the two syndromes","volume":"18","year":"2015","journal-title":"Asian J Psychiatr"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","year":"2003","journal-title":"QJM"},{"key":"bib5-20231002","first-page":"155","article-title":"Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management","volume":"24","year":"2012","journal-title":"Ann Clin Psychiatry"},{"key":"bib6-20231002","first-page":"e50","article-title":"Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool","volume":"45","year":"2011","journal-title":"Ann Pharmacother"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/10401230600801259","article-title":"Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: case analysis","volume":"18","year":"2006","journal-title":"Ann Clin Psychiatry"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4088\/PCC.v09n0211b","article-title":"Aripiprazole as the causative agent of neuroleptic malignant syndrome: a case report","volume":"9","year":"2007","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/cap.2008.0130","article-title":"Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review","volume":"19","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/01.chi.0000209786.29479.74","article-title":"Neuroleptic malignant syndrome and aripiprazole","volume":"45","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"bib11-20231002","article-title":"A case of serotonin syndrome following cyproheptadine withdrawal","volume":"17","year":"2015","journal-title":"Prim Care Companion CNS Disord"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/2045125314561467","article-title":"Serotonin syndrome with a combination of aripiprazole and fluoxetine: a case report","volume":"5","year":"2015","journal-title":"Ther Adv Psychopharmacol"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.283.8.1025","article-title":"Trends in the prescribing of psychotropic medications to preschoolers","volume":"283","year":"2000","journal-title":"JAMA"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000001477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T21:06:20Z","timestamp":1696280780000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000001477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000001477","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"value":"1535-1815","type":"electronic"},{"value":"0749-5161","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}